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Electrospray ionization mass spectrometry (ESI-MS) was used to measure conformational 
changes within the DNA-binding domain of the vitamin D receptor (VDR DBD) upon binding 
zinc (Zn2’). As increasing concentrations of Zn2+ were added to the VDR DBD, a gradual shift 
in the mass envelope to lower charge states was observed in the multiply charged spectrum. 
The shift in the charge states was correlated to changes observed in the far-ultraviolet circular 
dichroic (far-UV CD) spectrum of the protein as it was titrated with Zn*+. Both the multiply 
charged ES1 and far-UV CD spectra of the Zn*+ -titrated protein show that the binding of the 
first Zr?+ ion to the protein results in very little conformational change in the protein. The 
binding of a second Zn2’ ion resulted in a significant alteration in the structure of the protein 
as indicated by changes in both the multiply charged ES1 and far-UV CD spectra. Much smaller 
changes were seen within the multiply charged ES1 or far-UV CD spectra upon increasing the 
Zd’ concentration beyond 2 mol/mol of protein. The results presented indicate that ESI-MS 
in combination with CD is a powerful method to measure gross conformational changes 
induced by the binding of metals to metalloproteins. (J Am Sot Mass Spectrom 1998, 9, 
8-14) 0 1998 American Society for Mass Spectrometry 
E lectrospray ionization mass spectrometry (ESI- MS) [l] has found extensive use in the molecular weight determination of proteins [2, 31. More 
recently, it has proved useful in the analysis of nonco- 
valent protein-metal ion interactions. Specifically, 
Zn2’/Cd2+ metallothionens [4], Znzt-zinc finger pro- 
teins [5, 61, Zn*+/Cu*+ -estrogen receptor [6], Fe3’- 
rubredoxin [7], and Ca2+/Mg2+-calmodulin [B-lo] in- 
teractions have been investigated using this approach. 
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We have also described the use of ESI-MS to unequiv- 
ocally determine the stoichiometry of Ca*+ binding to 
calbindin D,, K and two recombinant mutant proteins 
[ll], and of Zn2’ binding to the human vitamin D 
receptor DNA binding domain [12]. Recently, Loo [13] 
has reviewed the analysis of polypeptide-metal inter- 
actions by ESI-MS as part of a larger review on nonco- 
valent protein complexes. 
The electrospray process produces multiply charged 
protein ions O-l eV above their ground state energies 
which results in little or no fragmentation of the pre- 
cursor ion [14]. The resulting Gaussian-like distribution 
of charge states are readily transformed to afford a 
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molecular weight determination of the intact protein [3, 
151. The number of multiply charged positive or nega- 
tive ions produced in the ESI-MS of proteins is related 
to the number of basic or acidic amino acid side chains, 
respectively, at the surface of the protein [3]. The charge 
state of these amino acids is ultimately related to their 
pKa values and solvent accessibility which both depend 
to a large extent on the conformational state of the 
protein. Indeed, a number of workers using predomi- 
nantly hydrogen/deuterium (H/D) exchange studies 
have no;ed that an apparent induced conformational 
change is detectable based on the charge distribution of 
the H/D ratio [16-181. However, although other work- 
ers have noted differences in the charge state distribu- 
tion of the apo- versus the metal-bound protein 16, 10, 
111, no one has systematically evaluated if this indeed 
represents a distinct and defined change in protein 
conforma.tion. 
In ordler to test the hypothesis that ESI-MS is able to 
detect conformational changes of a protein after binding 
metal ions, we compared changes in the multiply 
charged spectra during the titration of the DNA-bind- 
ing domain of the vitamin D receptor (VDR DBD) with 
Zn2’ to changes in the spectra of the protein measured 
by far-ultraviolet circular dichroism (far-UV CD). The 
WR DBD protein corresponds to the first 110 residues 
of the v:itamin D receptor (VDR), a protein that is 
known to regulate the transcription of more than 60 
genes in a vitamin D-dependent manner [19, 201. Pre- 
vious studies have shown that the protein possesses 
two high affinity Zn” -binding sites, as well as two sites 
that bind Zn2’ with lower affinity [12]. Our results 
show that changes in the multiply charged spectra of 
the protein upon titration with Zn2+ are reflected by 
detectablle changes in the conformation of the proteins 
as measured by far-UV CD. In addition, by combined 
use of the multiply charged and transformed ESI-MS 
spectra, we were able to detect the binding of two 
additional metal ions that were difficult to detect by 
far-UV CD. The results presented here indicate that 
ESI-MS c,an be used not only to measure metal-binding 
stoichiometries of proteins but also, in combination 
with CD,. to accurately detect conformational changes 
within the protein resulting from these interactions. 
Experimental 
Protein Expression and Purification 
Expression and purification of the VDR DBD were as 
described previously [12]. Briefly, DNA sequences of 
the VDR DBD were amplified by polymerase chain 
reaction (PCR) techniques 121, 221 using the cDNA for 
full length human VDR. Sequences encoding the VDR 
DBD were ligated into the Schisfosoma japonicum gluta- 
thioneS-transferase (GST) fusion protein vector (Phar- 
macia, Piscataway, NJ). E. coli BL21 cells were made 
competent and transformed with the chimeric plasmid. 
Bacterial cultures containing the expression plasmid 
were grown at 37°C and 360 rpm until an o.d., nm of 1 
was achieved and protein expression was induced by 
the addition of isopropyl thio-P-D-galactosidase to 0.1 
mM. Bacteria were cultured for an additional 12 h at 
20°C. Cells were harvested by centrifugation and the 
crude protein was isolated using the manufacturer’s 
protocol (I’harmacia). The VDR DBD was purified to 
homogeneity by applying the crude protein extract to a 
Mono S column and eluting the VDR DBD with an 
increasing NaCl gradient. The VDR DBD eluted at 
approximately 0.4 M NaCl. Column fractions contain- 
ing pure WR DBD protein were pooled and dialyzed 
against 50 mM Tris, 10 mM DTT, pH 8.0. Protein 
samples were stored at 4°C prior to use. 
Electrospray Ionization Mass Spectromety 
ESI-MS measurements were done on a Finnigan MAT 
900 mass spectrometer (Bremen, Germany), a double 
focusing instrument of EB geometry. ES1 measurements 
of the Zn*‘-binding stoichiometry of VDR DBD were 
done in positive ion mode and confirmed by negative 
ion ionization studies. To prevent formation of corona 
discharge in the ES1 source for all measurements done 
in the negative ion mode, sulfur hexafluoride was 
introduced through the auxiliary gas port at 2 L/min. 
Protein solutions were introduced into the ES1 source at 
a flow rate between 0.2 and 0.3 pL/min via 50 pm id. 
fused silica, using a 50 PL syringe, and a Harvard 
Apparatus Model 22 syringe pump (South Natick, MA). 
The instrument was scanned from m/z 600 to 6000 at a 
rate of lo-30 s per decade, employing an instrument 
resolution between 1000 and 2000. Clusters of cesium 
iodide (CsI) were used as the mass reference to calibrate 
the mass-to-charge ratio axis in positive ion mode. 
Although it has been reported that calibration in nega- 
tive ion ESI-MS is possible using CsT [23], in our hands 
this has proved problematic due to the lack of an ion 
response over the desired mass-to-charge ratio range. 
Alternatively, we have created a magnet calibration 
curve from m/z 133 to 6888 via LSIMS in the positive 
ion mode using clusters of CsI as the mass reference. A 
solution of CsI in methanol/water was then used to 
lock the calibration curve in negative ion ES1 operation 
at m/z 3504 by modifying the accelerating voltage 
using the instrument parameter em-r. ECORR functions 
as a scalar or gain to the calibration curve, making 
proportional changes to the mass-to-charge ratio axis. 
After adjustment of the ecorr parameter, the molecular 
weight of apo-calmodulin was measured to within 
0.01% of its calculated molecular weight of 16,790. 
Regeneration of the magnet calibration curve is typi- 
cally required every two to four weeks when working 
within this mass-to-charge ratio range. The position and 
time resolved ion counter (PATRIC) array detector was 
used for ion detection. Multiple scans were recorded 
and summed by the instrument data system (Finnigan 
MAT ICIS software, version 8.01 HB), and the multiply 
charged spectra were transformed into the M, scale 
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using algorithms supplied with the instrument data 
system. 
For ESI-MS measurements the VDR DBD was ab- 
sorbed onto a reverse phase microguard column, 
washed twice, and eluted with 10 FL of CHaCN/H,O/ 
n-&OH/glacial AcOH/TFA (-55/10/35/0.5/0.01 v/ 
v/v/v/v). This solution was diluted tenfold with a 
buffer containing 4 mM NH,HCO,, 10 PM EDTA, pH 
8.0. 
Circular Dichroism Spectroscopy 
Far UV-CD measurements (190-250 nm) of the VDR 
DBD were recorded on a JASCO J-710 spectropolarim- 
eter equipped with a data processor. Measurements 
were made at 22°C in 4 mM NH,HCO,, 10 ,uM EDTA, 
1 mM DTT, pH 8.0, using a quartz cell with a path 
length of 0.49 mm. The concentration of the VDR DBD 
was 38 PM (0.49 mg/mL). A total of ten scans were 
recorded and averaged for each sample. All resultant 
spectra were baseline subtracted. To monitor the effect 
of Zn” on the conformation of the DNA-VDR, protein 
samples were recorded in the presence of 0, 10, 20, 50, 
90,130, and 210 FM added ZnCl,. Protein concentration 
was determined by amino acid analysis [24] and the 
mean residue ellipticity (MRE) was calculated [25] 
using a me.an residue molecular weight of 115. 
Results 
ESI-MS Studies of the Zinc-Binding Stoichiomety 
and Metal-Induced Conformational Change of the 
VDR DBD 
In order toI determine the Zn’+-binding stoichiometry 
of the VDR DBD, ESI-MS spectra of the protein in the 
apo-form and metal-bound form were acquired in the 
positive ion mode as shown in Figure 1. The ES1 
spectrum of the apo-protein had a distribution centered 
around the +ll (m/z 1166.2) charge state (Figure ZA). 
Transformation of this data yields two major responses 
at molecular weights (M,) 12,819 and 12,933 Da (Figure 
1B). The ion at 12,819 Da is consistent with the calcu- 
lated molecular weight of the protein. The ion at 12,933 
Da is an ion-pair, noncovalent adduct between the 
protein and the TFA anion (CF,COOO. . . HlN pro- 
tein), formed after elution of the protein from the 
microguand column in the presence of a trace amount of 
TFA. Such an adduct is not observed when only glacial 
acetic acid. is used to elute the protein off the micro- 
guard column [12]. The addition of a tenfold excess of 
Zr?” to the protein did not result in any sizable change 
in the multiply charged ES1 spectrum (Figure 1C); 
however, the transformed spectrum shows the presence 
of a single Zn2+ ion bound to the protein (M, = 12,882 
Da) and to the adducted protein (M, = 13,000 Da) 
(Figure 1D). A total of two protons were found to be 
displaced per bound Zn2’ in agreement with that 
shown in similar studies with other zinc-finger peptides 
1261. A significant shift in the multiply charged spec- 
trum of the protein to lower charge states (higher 
mass-to-charge ratio range) is observed when the con- 
centration of Zn2+ is increased to a 20-fold excess of 
protein (Figure lE), and the transformed spectrum 
shows the protein is now bound by two Zn2+ ions (M, 
= 12,944 Da) (Figure 1F). It has been shown previously 
by ESI-MS [12] that when the VDR DBD is not pre- 
treated with excess amounts of Zn2+ or EDTA, the 
protein binds two Zn” ions with high affinity. The 
multiply charged ES1 spectrum of the protein in a 
50-fold excess of Zn” shows a further, albeit consider- 
ably smaller, shift in the charge states so that the lower 
mass-to-charge ratio ion series envelope is no longer 
observable (Figure 1G). The transformed spectrum 
shows the protein is now bound to a total of four Zn2+ 
ions (Figure 1H). Addition of Zn2’ to a loo-fold excess 
resulted in a transformed spectrum showing four Zn2+ 
ions bound to the protein as the predominant species; 
however, no further change in the ES1 multiply charged 
spectrum was observed (data not shown). The binding 
of the additional two Zn2+ ions appears to be at lower 
affinity binding sights, as described previously [12]. 
To investigate the observed shift in the charge states 
of the acquired positive ion spectrum of the protein and 
confirm the Zn2+-binding stoichiometry of the VDR 
DBD, ESI-MS spectra of the protein in the apo- and 
metal-bound state were acquired in the negative ion 
mode as shown in Figure 2A and B. In the apo-protein 
(Figure 2A) the predominant charge states are centered 
around -9, -10, and -11. However, on addition of a large 
excess Zn2+ (1 mM), the multiply charged spectrum 
shifts significantly to predominant charge states cen- 
tered about -6, -5, and -4 (Figure 2B). The transformed 
spectrum of the multiply charged spectrum in Figure 2B 
revealed a broad response but with a clear signal 
containing four Zn” ions bound to the protein (data 
not shown). It is likely that the broadness of the 
responses in negative ion ESI-MS is due to nonspecific 
binding of numerous anions such as Cl- present in 
solution, since the pl of VDR DBD is 10.8 [12]. It could 
be argued that the addition of the positively charged 
metal ions to the protein would neutralize existing 
negative charges in the protein and, thereby, cause a 
shift in the multiply charged spectrum to lower charge 
states (higher mass-to-charge ratio) in the negative ion 
mode. However, the same argument would suggest 
that in the positive ion mode the addition of Zn” 
would cause a shift in the multiply charged spectrum to 
higher charge states (lower mass-to-charge ratio). 
The ratio of the intensities of the two dominating 
peaks in the high mass-to-charge ratio envelope (m/z 
1660.6, +8 charge state) and the low mass-to-charge 
ratio envelope (m/z 1166.0, +ll charge state) was 
determined for a series of Zn2’/VDR DBD ratios and 
compared to the number of ions bound to the protein 
observed within the corresponding transformed spec- 
tra. The peaks at m/z 1660.6 and 1166.0 were selected 
based on the dominant charge states seen in the ES1 
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Figure 1. Multiply charged positive ion and transformed ESI-MS spectra of the VDR DBD in the 
presence of (A,B) 0-, (C,D) lo-, (E,F) 20-, and (G,H) 50-fold excess Zn’+. 
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Figure 2. Negative ion ESI-MS spectra of the VDR DBD in the 
(A} apo form and (B} in the presence of 1 mM of Zn”. The protein 
(60 FM) was dissolved in 4 mM NH,HCO,, 10 PM EDTA, 15% 
CH,OH, pH 8.0. 
multiply charged spectra of the VDR DBD in the apo 
and holo forms. As seen in Table 1, in transformed 
spectra where the predominant peak corresponds to 
zero and one Zn*+ ions bound to the protein, there is 
little change in the intensity ratio calculated from the 
corresponding multiply charged spectra. However, 
when two Zn2’ ions are bound to the VDR DBD, the 
intensity ratio between the high and low rnass-to- 
charge ratio states increases dramatically. Increasing 
the number of Zn2+ ions bound to the protein also 
results in a change in the intensity ratios, although not 
Table 1. Intensity ratio of high mass-to-charge ratio peak 
(+ll) to low mass-to-charge ratio peak (+8) versus number of 
bound Zn2+ ions 
Number of bound Zn*+ High (m/z)/Low (m/z) 
0 (0) 0.43 
o*-1 (1) 0.41 
o*-1 (5) 0.32 
o*-1 x-2 (IO) 0.55 
o-1-2* (i!O) 1.47 
2*-3 (30) 1.77 
2*-3-4 (40) 1.50 
2*-3*-4 (50) 1.92 
+Predomin,snt species in deconvoluted spectrum. 
The numbers in brackets represent the solution Zr?+/protein ratio. 
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Figure 3. Circular dichroism spectra of the VDR DNA-BD. The 
CD spectra of the VDR DBD in the presence of solid line: 0 FM 
&Cl,; dashed line: 50 FM ZnCl,; dot-dashed line: 90 FM ZnCJ,; 
dotted line: 130 PM ZnCl, are shown. The protein (38 PM) was 
dissolved in 4 mM NH,HCO, 10 PM EDTA, 1 mM DTT, pH 8.0. 
nearly as great as that seen for the binding of the second 
ion. 
Far-UV CD Spectroscopy Studies of the Zinc- 
Induced Confovmational Change Within the VDR 
DBD 
The pattern of changes observed within the multiply 
charged ES1 spectrum of the VDR DBD were compared 
to changes in the far-LJV CD spectrum of the protein as 
Zn*+ was added at the same basic pH (pH 8.0). The 
addition of Zn2+ to a solution of the VDR DBD has been 
shown to cause a change in the conformation of the 
protein by far-UV CD 1201. The far-UV CD spectra of the 
protein (38 PM) in 0,50,90 and 130 FM Zn2” are shown 
in Figure 3. There is no change in the far-UV CD 
spectrum of the protein between the 0 and IO FM added 
2n2+, as expected, since the buffer contained 10 PM 
EDTA to ensure the protein did not bind any extrane- 
ous metals arising from sources, such as glassware, 
before beginning the far-UV CD experiments. The ad- 
dition of Zn2+ to 20 PM and 50 PM (Zn2’/protein ratio 
of 1.1) shows no significant change in the far-UV CD 
spectrum. In particular, no change in the mean residue 
ellipticity (MRE) values at 222 nm are seen, which are 
indicative of changes in the helical content of the 
protein. However, when the Zn2+ concentration is 
increased to 90 +M (metal/protein ratio of about 2.1), 
there is a large change in the far-UV CD spectra 
primarily reflected in a decrease in the MRE at 222 nm, 
as well as a shift in the band at 206-208 nm, which is 
accompanied by a large decrease in magnitude. Titra- 
tion of the VDR DBD with Mg’+ did not result in any 
observable change in the conformation of the protein as 
detected by CD. The change in the MRE at 222 nm in the 
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Table 2. Mean residue ellipticity at 222 nrn of the VDR DBD at 
various concentrations of Zn”. Numbers in brackets represent 
the Zn’+/proteti ratio 
[Zr?‘]/[VDR DBDI MRE 222 nm 
0 -5583.75 
10 (0) -5371.88 
20 (0.3) -5190.63 
40 (1.1) -5586.88 
80 (2.1) -6978.30 
120 (3.2) -6645.31 
200 (5.3) -6390.63 
far-UV CD spectrum of the VDR DBD at all of the 
metal/protein molar ratios used is shown in Table 2. 
Comparison of Tables 1 and 2 show that the pattern of 
changes within the far-UV CD spectrum and ES1 mul- 
tiply charged spectrum of VDR DNA-BD are similar in 
that there is little change in either spectrum at lower 
Zn2+ concentrations; however, the binding of the sec- 
ond Zn2+ results in the greatest changes in both spectra. 
Discussion 
The far-UV CD spectroscopy data presented shows 
there is no significant change in the spectrum of the 
VDR DBD at a Zn2+/protein ratio of 1, which suggests 
the binding of a single Zn2+ ion causes little if any 
change in the structure of the protein. However, in- 
creasing the Zn2+/protein ratio to about 2 results in a 
significant change in the CD spectrum indicating that 
the binding of a second Zn2+ ion to the VDR DBD 
results in a large structural change. Coincidentally, no 
change between the low and high mass-to-charge ratio 
states within the ESI-MS spectra of the apo-protein and 
the protein bound to a single Zn*+ ion are observed, as 
shown in Figure 1 and Table 1. When the VDR DBD is 
bound to two Zn2’ ions, as seen in the transformed ES1 
spectrum, a large shift in the intensities of the low and 
high mass-to-charge ratio states occurs. Both the far-UV 
CD and ESI-MS spectra exhibit smaller changes as the 
Zn2’/protein ratio is increased. Therefore, the data 
suggests that the degree of shift in the intensities of the 
charge states observed in the ESI-MS spectrum is di- 
rectly related to the extent of conformational change 
within the protein. 
Other techniques used to measure metal-binding 
stoichiometry and conformational changes within met- 
alloproteins, including CD spectroscopy, fluorescence 
spectroscopy, and nuclear magnetic resonance spectros- 
copy (NMR), rely on a change in signal arising from the 
protein [27]. Small changes within the CD, fluorescence, 
or NMR spectra can be problematic in assigning to the 
actual binding of a metal ion. Therefore, no metal- 
protein interaction is detected in cases where the bind- 
ing of a metal to the protein does not give rise to a 
conformational change within the protein. ESI-MS is 
equally adept at detecting both bound metals that cause 
conformational changes within the protein and bound 
metals that do not. The transformed ES1 spectrum of the 
VDR DBD loaded with Zn2+ unequivocally show the 
binding of a third and fourth Zn*’ ion to the protein; 
whereas the binding of these ions is not readily appar- 
ent by examining the far-UV CD spectra. Based on a 
series of other physical measurements including analy- 
sis, mono S chromatography, and ICP-MS, it is sug- 
gested that uptake of the two additional Zn2+ ions 
occurs at lower affinity binding sites [12]. Because ES1 
detects bound metals without relying on a change in the 
signal arising from the protein, metal ions that do not 
cause a change in the conformation of the protein are 
detected equally as well as those that do. 
If the changes within the multiply charged ES1 
spectrum upon metal binding to the protein were a 
direct result of the binding of a charged species, the 
changes observed in the positive and negative ion 
spectra would be opposite of one another. However, 
acquisition of the ES1 spectrum of the VDR DBD in both 
the positive and negative ion mode gave similar shifts 
to lower charge states (higher mass-to-charge ratio) 
upon Zn*’ binding. In the measurements of the binding 
of Zn2+ and Cu2+ to the DNA-binding domain of the 
estrogen receptor, it has also been observed that only 
the binding of Cu*+ to the receptor resulted in a change 
in the multiply charge envelope [6]. Also, shifts in the 
multiply charged spectra of calbindin D2a k and two 
deletion mutants of the protein were observed for both 
the Ca’+- and Tb3+-loaded forms [ll]. These observa- 
tions precluded the suggestion that changes in the 
charge states of the protein are a result of a direct 
contribution of the charge state of the bound metal. In 
general, the binding of a metal cation to a protein causes 
the displacement of the number of protons required to 
preserve the charge of the protein, therefore maintain- 
ing the charge of the system. This would suggest that no 
change in the multiply charged spectrum should be 
observed upon metal binding to the protein; however, 
as we and others have shown, a significant change 
occurs within the spectrum upon adding metals to 
various metalloproteins [lo, 11, 131. 
Metal-binding stoichiometries are often determined 
by measuring the metal to protein ratio with an excess 
of metal ions which results in no further changes of the 
acquired spectra. Such measurements require precise 
and accurate metal and protein concentration measure- 
ments. Small errors in concentration measurements can 
often lead to nonintegral values for metal-binding sto- 
ichiometries. Because ESI-MS is a direct technique, 
errors in concentration measurements do not influence 
the number of metal ions that are observed to bind to 
the protein. The same principle applies in the determi- 
nation of which metals cause a change in the conforma- 
tion of the protein. Changes within the ESI-MS multiply 
charged spectrum can be correlated to the appearance 
of bound metals seen within the corresponding trans- 
formed spectrum. However, it is interesting to note that 
a large excess (1050-fold) of metal ion/protein is 
required to effect such changes (Figure 1 and Table 1). 
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This is in contrast to the more reasonable stoichiome- 
tries (l-54old) needed in solution chemistry using 
optical spectroscopy such as CD (Table 2). In the former 
case, numerous other workers have noted that a large 
excess of metal ions are required [6, 9-11, 131 and 
presumably this reflects some of the unique properties 
of ESI-MS which may result in metal ion stripping. 
The results presented here show that ESI-MS is a 
new, potentially very useful tool in determining metal- 
binding stoichiometry and metal-induced conforma- 
tional changes within metalloproteins. Very recently 
Nemirovskiy et al. [28] also demonstrated the potential 
of this approach by showing that the calcium-induced 
conformational change of calmodulin results in a non- 
covalent complex with melittin. Our results presented 
here show that changes within the ESI-MS multiply 
charged spectra are consistent with changes observed in 
the far-U\7 CD spectra of the VDR DBD upon Zn2+ 
binding. However, because ESI-MS directly measures 
metal binding, metals that do not cause conformational 
changes within the protein are detected equally as well 
as those that give rise to structural changes. 
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